Leica Biosystems to Acquire StatLab Medical Products

July 15, 2026
Leica Biosystems has announced an agreement to acquire StatLab Medical Products, expanding its portfolio in anatomic pathology solutions. The deal is expected to close by the end of 2026, pending regulatory approval.

Leica Biosystems has entered into a definitive agreement to acquire StatLab Medical Products, announced in a press release. StatLab is a developer and manufacturer of anatomical pathology products that support laboratories across specimen collection, tissue processing, and slide preparation.

Following the completion of the transaction, StatLab will become part of Leica Biosystems. The acquisition aims to combine StatLab’s product portfolio with Leica Biosystems’ expertise in pathology and diagnostics supported by AI. The companies stated that their combined capabilities will help laboratories improve consistency, standardization, and diagnostic quality.

The deal is expected to close by the end of 2026, subject to customary regulatory approvals. Financial terms of the acquisition were not disclosed.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Funding News AI Brief AI Brief (X)

More from: Life Sciences

07/15
InsideDesk Raises $12.6 Million to Expand AI Platform for Dental Revenue Cycle Management
07/15
GW RhythmX Launches RhythmX Pulse on Microsoft Marketplace
07/15
Autonomous Healthcare Receives FDA Authorization for Syncron-E Ventilator Analysis Software
07/15
Brainify.AI Launches Cognitive Wellness Platform with The Longevity Suite in Riyadh
07/15
EHVA.ai Partners with CareFactor to Automate Provider Calls Using Voice AI

More from: Funding

07/15
InsideDesk Raises $12.6 Million to Expand AI Platform for Dental Revenue Cycle Management
07/15
Pratt & Whitney Expands AI Engine Inspection Capabilities with Aiir Innovations
07/15
State Affairs Raises $70 Million for Policy Intelligence Platform
07/15
Veterans Benefits Software Acquires VisPro and Launches Enhanced Claims Platform
07/15
Hadrius Raises $27 Million to Expand AI Compliance Infrastructure

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like